SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-076157
Filing Date
2019-12-26
Accepted
2019-12-26 16:30:29
Documents
6
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-26827_18k.htm 8-K 40152
2 EX-3.1 a19-26827_1ex3d1.htm EX-3.1 100233
3 EX-4.1 a19-26827_1ex4d1.htm EX-4.1 96387
4 EX-10.1 a19-26827_1ex10d1.htm EX-10.1 205165
5 EX-10.2 a19-26827_1ex10d2.htm EX-10.2 70698
6 EX-10.3 a19-26827_1ex10d3.htm EX-10.3 37821
  Complete submission text file 0001104659-19-076157.txt   551824
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 191310847
SIC: 2834 Pharmaceutical Preparations